In addition, the two distinct genetic backgrounds gave an opportunity to address tumor efficacy in the context of their propensities toward different immune polarization, for example, type 1 versus type 2 immunity, since CD27-CD70 interactions have been often associated with type 1 responses (19). The gene discussed is CD70; the disease is neoplasm.